The world is currently experiencing a huge challenge which has affected all the industries and markets. Few markets have experienced a high growth in their demand while others have faced a downfall. The extent of growth or drop in the market statistics of different industries by COVID 19 plays an important role in how the future of businesses will shape up in the near future. We at Value Market Research provide you with an impact analysis of COVID 19 on this market with its latest update in the purchased version of the report.
Global Cancer Biopsy Market Report By Product (Instruments, Kits and Consumables, Services), By Type (Tissue Biopsies( Needle Biopsies, Fine Needle Aspiration (FNA), Core Needle Biopsy (CNB), Surgical Biopsies), Liquid Biopsies, Others), By Application (Breast Cancer, Colorectal Cancer, Cervical Cancers, Lung Cancers, Prostate Cancers, Skin Cancers, Blood Cancers, Kidney Cancers, Liver Cancers, Pancreatic Cancers, Ovarian Cancers, Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028
ID:VMR11213945
April 2021
Report Formats: Electronic (PDF), MS EXCEL
Global Cancer Biopsy Market Overview
The key driver impacting the cancer biopsy market is the growing prevalence of cancer across the globe. Thus, it creates more demand for cancer biopsies and tissue sectioning as it assists doctors to get significant information concerning oncological molecular profiling. For instance, According to a WHO report, Globally, cancer is the second leading cause of death and accounts for 9.6 million deaths in 2018. For instance, According to a WHO report, Globally, cancer is the second leading cause of death and accounts for 9.6 million deaths in 2018. There are 1 in 6 deaths that take place due to cancer. The most common cancers are Breast cancer (2.09 million cases), Lung cancer(2.09 million cases), Colorectal (1.80 million cases), and Prostate (1.28 million cases).
Moreover, the several benefits provided by fine-needle aspiration (FNA) type needle biopsies, such as minimal incision on the skin, and shorter wait time for the results, is also estimated to be a significant determinant that adds growth to the market.
In addition to this, the evolution of novel oncology diagnostics from bench to clinics is also predictable to enhance market growth under the forecast period.
However, the high risks associated with biopsy procedures may hamper the global cancer biopsy industry in the long run. The current industry trend, such as the series of advancements in image-guided biopsies and its expanding applications, is expected to create new market opportunities for the key players in the coming years.
The Cancer biopsy market is vast, with a large number of local and global players. The key leaders follow different strategies to improve their market position, such as mergers, expansions, acquisitions, and product innovations to augment their market share across the world. For instance, in February 2020, Qiagen received CE Mark for its mutation assay named rascreen PIK3CA RGQ PCR kit, which is developed to detect breast cancer patients with PIK3CA mutation. The key players included in the report are Qiagen N.V., GRAIL, Inc, Illumina, Inc., ANGLE Plc, BD (Becton, Dickinson And Company), Myriad Genetics, Hologic, Inc., Biocept, Inc., Thermo Fisher Scientific, Inc., Danaher, F. Hoffmann-La Roche Ltd., Lucence Diagnostics Pte. Ltd., Guardant Health, Exact Sciences Corporation, Biodesix (Integrated Diagnostics), Freenome Holdings, Inc.
In this research report, the cancer biopsy market is segmented by product, type, application, and region.
Analysis by Product:
By product, the report is categorized into Instruments, Kits & Consumables, Services. The Kits & Consumables segment dominates the product type segment in 2019, with a 60% market share. It is essential across various stages of biopsies, and growing developments in terms of kits and consumables are certain factors driving the product segment of the cancer biopsy market in the forecast period. Moreover, the rising investment by key players in developing highly accurate and effective kits is also adding growth to the kits & consumables segment across the forecast period.
Analysis by Type:
By type, the report is categorized into tissue biopsies(needle biopsies, fine needle aspiration (FNA), Core needle biopsy (CNB), Surgical Biopsies), liquid biopsies, and others. Tissue biopsies dominate the type segment in 2019 with a maximum market share of 80%. It is due to the extensive adoption across various cancer diagnosis applications as it is the safest and highly effective biopsy procedure, thus expected to drive demand in the forecast period. Moreover, the rising technological advancement to enhance tissue biopsy procedures contributes to the increasing demand in the forecast period.
Analysis by Application:
By application, the report is categorized into breast cancer, colorectal cancer, cervical cancers, lung cancers, prostate cancers, skin cancers, blood cancers, kidney cancers, liver cancers, pancreatic cancers, ovarian cancers, and others. The breast cancer segment is accounted for the largest share of 15% in 2019. It is due to the growing prevalence of breast cancer across the globe. According to the U.S. breast cancer statistics, there are 1 in 8 U.S. women (about 12%) build up invasive breast cancer throughout their lifetime. In 2020, around 276,480 invasive breast cancer new cases are estimated to be diagnosed in U.S. women together with over 48,530 new non-invasive (in situ) breast cancer cases. Moreover, the growing need for microscopic analysis of breast tissue to get,t definitive diagnosis together with detection of the stage and characterization of type in patients is expected to create more demand for cancer biopsy in breast cancer application in the forecast period.
Analysis by Region:
In the regional outlook of the global cancer biopsy market, the North America region shows considerable growth in the forecast period. It is expected to show massive growth due to the increasing adoption of liquid biopsies and favorable policies made by regulatory authorities across the U.S. Moreover, the growing focus of manufacturers operating in this region to develop novel kits that are compatible for rapid diagnostic applications contributes to the growth of the cancer biopsy market across North America.
Market Segmentation covered in the Report:
By Product
By Type
By Application
By Region
The key driver impacting the cancer biopsy market is the growing prevalence of cancer across the globe. Thus, it creates more demand for cancer biopsies and tissue sectioning as it assists doctors to get significant information concerning oncological molecular profiling. For instance, According to a WHO report, Globally, cancer is the second leading cause of death and accounts for 9.6 million deaths in 2018. For instance, According to a WHO report, Globally, cancer is the second leading cause of death and accounts for 9.6 million deaths in 2018. There are 1 in 6 deaths that take place due to cancer. The most common cancers are Breast cancer (2.09 million cases), Lung cancer(2.09 million cases), Colorectal (1.80 million cases), and Prostate (1.28 million cases).
Moreover, the several benefits provided by fine-needle aspiration (FNA) type needle biopsies, such as minimal incision on the skin, and shorter wait time for the results, is also estimated to be a significant determinant that adds growth to the market.
According to Value Market Research, the global cancer biopsy market was valued at around USD 20 billion in 2019 and is estimated to grow at a CAGR of about 6.25% during the forecast period of 2020-2026.
In addition to this, the evolution of novel oncology diagnostics from bench to clinics is also predictable to enhance market growth under the forecast period.
However, the high risks associated with biopsy procedures may hamper the global cancer biopsy industry in the long run. The current industry trend, such as the series of advancements in image-guided biopsies and its expanding applications, is expected to create new market opportunities for the key players in the coming years.
The Cancer biopsy market is vast, with a large number of local and global players. The key leaders follow different strategies to improve their market position, such as mergers, expansions, acquisitions, and product innovations to augment their market share across the world. For instance, in February 2020, Qiagen received CE Mark for its mutation assay named rascreen PIK3CA RGQ PCR kit, which is developed to detect breast cancer patients with PIK3CA mutation. The key players included in the report are Qiagen N.V., GRAIL, Inc, Illumina, Inc., ANGLE Plc, BD (Becton, Dickinson And Company), Myriad Genetics, Hologic, Inc., Biocept, Inc., Thermo Fisher Scientific, Inc., Danaher, F. Hoffmann-La Roche Ltd., Lucence Diagnostics Pte. Ltd., Guardant Health, Exact Sciences Corporation, Biodesix (Integrated Diagnostics), Freenome Holdings, Inc.
In this research report, the cancer biopsy market is segmented by product, type, application, and region.
Analysis by Product:
By product, the report is categorized into Instruments, Kits & Consumables, Services. The Kits & Consumables segment dominates the product type segment in 2019, with a 60% market share. It is essential across various stages of biopsies, and growing developments in terms of kits and consumables are certain factors driving the product segment of the cancer biopsy market in the forecast period. Moreover, the rising investment by key players in developing highly accurate and effective kits is also adding growth to the kits & consumables segment across the forecast period.
Analysis by Type:
By type, the report is categorized into tissue biopsies(needle biopsies, fine needle aspiration (FNA), Core needle biopsy (CNB), Surgical Biopsies), liquid biopsies, and others. Tissue biopsies dominate the type segment in 2019 with a maximum market share of 80%. It is due to the extensive adoption across various cancer diagnosis applications as it is the safest and highly effective biopsy procedure, thus expected to drive demand in the forecast period. Moreover, the rising technological advancement to enhance tissue biopsy procedures contributes to the increasing demand in the forecast period.
Analysis by Application:
By application, the report is categorized into breast cancer, colorectal cancer, cervical cancers, lung cancers, prostate cancers, skin cancers, blood cancers, kidney cancers, liver cancers, pancreatic cancers, ovarian cancers, and others. The breast cancer segment is accounted for the largest share of 15% in 2019. It is due to the growing prevalence of breast cancer across the globe. According to the U.S. breast cancer statistics, there are 1 in 8 U.S. women (about 12%) build up invasive breast cancer throughout their lifetime. In 2020, around 276,480 invasive breast cancer new cases are estimated to be diagnosed in U.S. women together with over 48,530 new non-invasive (in situ) breast cancer cases. Moreover, the growing need for microscopic analysis of breast tissue to get,t definitive diagnosis together with detection of the stage and characterization of type in patients is expected to create more demand for cancer biopsy in breast cancer application in the forecast period.
Analysis by Region:
In the regional outlook of the global cancer biopsy market, the North America region shows considerable growth in the forecast period. It is expected to show massive growth due to the increasing adoption of liquid biopsies and favorable policies made by regulatory authorities across the U.S. Moreover, the growing focus of manufacturers operating in this region to develop novel kits that are compatible for rapid diagnostic applications contributes to the growth of the cancer biopsy market across North America.
Market Segmentation covered in the Report:
By Product
- Instruments
- Kits and Consumables
- Services
By Type
- Tissue Biopsies( Needle Biopsies, Fine Needle Aspiration (FNA), Core Needle Biopsy (CNB), Surgical Biopsies)
- Liquid Biopsies
- Others
By Application
- Breast Cancer
- Colorectal Cancer
- Cervical Cancers
- Lung Cancers
- Prostate Cancers
- Skin Cancers
- Blood Cancers
- Kidney Cancers
- Liver Cancers
- Pancreatic Cancers
- Ovarian Cancers
- Others
By Region
- North America
- Europe
- the Asia Pacific
- Latin America
- The Middle East and Africa
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
TABLE OF CONTENTS
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . CANCER BIOPSY – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 By Product
3.7.2 By Type
3.7.3 By Application
3.7.4 By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
5.1. Impact Analysis of Covid-19 Outbreak
5.1.1. Direct Impact on Production
5.1.2. Supply Chain and Market Disruption
5.1.3. Financial Impact on Firms and Financial Markets
5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
5.3. Market: Pre V/S Post COVID-19
5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
5.5. COVID-19: Micro and Macro Factor Analysis
6 . GLOBAL CANCER BIOPSY MARKET ANALYSIS BY PRODUCT
6.1 Overview by Product
6.2 Historical and Forecast Data
6.3 Analysis by Product
6.4 Instruments Market by Regions
6.6 Kits and Consumables Market by Regions
6.5 Services Market by Regions
7 . GLOBAL CANCER BIOPSY MARKET ANALYSIS BY TYPE
7.1 Overview by Type
7.2 Historical and Forecast Data
7.3 Analysis by Type
7.4 Tissue Biopsies( Needle Biopsies, Fine Needle Aspiration (FNA), Core Needle Biopsy (CNB), Surgical Biopsies) Market by Regions
7.5 Liquid Biopsies Market by Regions
7.6 Others Market by Regions
8 . GLOBAL CANCER BIOPSY MARKET ANALYSIS BY APPLICATION
8.1 Overview by Application
8.2 Historical and Forecast Data
8.3 Analysis by Application
8.4 Breast Cancer Market by Regions
8.5 Colorectal Cancer Market by Regions
8.6 Cervical Cancers Market by Regions
8.7 Lung Cancers Market by Regions
8.8 Prostate Cancers Market by Regions
8.9 Skin Cancers Market by Regions
8.10. Blood Cancers Market by Regions
8.11 Kidney Cancers Market by Regions
8.12 Liver Cancers Market by Regions
8.13 Pancreatic Cancers Market by Regions
8.14 Ovarian Cancers Market by Regions
9 . GLOBAL CANCER BIOPSY MARKET ANALYSIS BY GEOGRAPHY
9.1. Regional Outlook
9.2. Introduction
9.3. North America
9.3.1. Overview, Historic and Forecast Data
9.3.2. North America By Segment
9.3.3. North America By Country
9.3.4. United State
9.3.5. Canada
9.3.6. Mexico
9.4. Europe
9.4.1. Overview, Historic and Forecast Data
9.4.2. Europe by Segment
9.4.3. Europe by Country
9.4.4. United Kingdom
9.4.5. France
9.4.6. Germany
9.4.7. Italy
9.4.8. Russia
9.4.9. Rest Of Europe
9.5. Asia Pacific
9.5.1. Overview, Historic and Forecast Data
9.5.2. Asia Pacific by Segment
9.5.3. Asia Pacific by Country
9.5.4. China
9.5.5. India
9.5.6. Japan
9.5.7. South Korea
9.5.8. Australia
9.5.9. Rest Of Asia Pacific
9.6. Latin America
9.6.1. Overview, Historic and Forecast Data
9.6.2. Latin America by Segment
9.6.3. Latin America by Country
9.6.4. Brazil
9.6.5. Argentina
9.6.6. Peru
9.6.7. Chile
9.6.8. Rest of Latin America
9.7. Middle East & Africa
9.7.1. Overview, Historic and Forecast Data
9.7.2. Middle East & Africa by Segment
9.7.3. Middle East & Africa by Country
9.7.4. Saudi Arabia
9.7.5. UAE
9.7.6. Israel
9.7.7. South Africa
9.7.8. Rest Of Middle East And Africa
10 . COMPETITIVE LANDSCAPE OF THE CANCER BIOPSY COMPANIES
10.1. Cancer Biopsy Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments
11 . COMPANY PROFILES OF CANCER BIOPSY INDUSTRY
11.1. Company Share Analysis
11.2. Market Concentration Rate
11.3. Qiagen N.V.
11.3.1. Company Overview
11.3.2. Financials
11.3.3. Products
11.3.4. Recent Developments
11.4. GRAIL, Inc
11.4.1. Company Overview
11.4.2. Financials
11.4.3. Products
11.4.4. Recent Developments
11.5. Illumina, Inc.
11.5.1. Company Overview
11.5.2. Financials
11.5.3. Products
11.5.4. Recent Developments
11.6. ANGLE Plc
11.6.1. Company Overview
11.6.2. Financials
11.6.3. Products
11.6.4. Recent Developments
11.7. BD (Becton, Dickinson And Company)
11.7.1. Company Overview
11.7.2. Financials
11.7.3. Products
11.7.4. Recent Developments
11.8. Myriad Genetics
11.8.1. Company Overview
11.8.2. Financials
11.8.3. Products
11.8.4. Recent Developments
11.9. Hologic, Inc.
11.9.1. Company Overview
11.9.2. Financials
11.9.3. Products
11.9.4. Recent Developments
11.10. Biocept, Inc.
11.10.1. Company Overview
11.10.2. Financials
11.10.3. Products
11.10.4. Recent Developments
11.11. Thermo Fisher Scientific, Inc.
11.11.1. Company Overview
11.11.2. Financials
11.11.3. Products
11.11.4. Recent Developments
11.12. Danaher
11.12.1. Company Overview
11.12.2. Financials
11.12.3. Products
11.12.4. Recent Developments
11.13. F. Hoffmann-La Roche Ltd.
11.13.1. Company Overview
11.13.2. Financials
11.13.3. Products
11.13.4. Recent Developments
11.14. Lucence Diagnostics Pte. Ltd.
11.14.1. Company Overview
11.14.2. Financials
11.14.3. Products
11.14.4. Recent Developments
11.15. Guardant Health
11.15.1. Company Overview
11.15.2. Financials
11.15.3. Products
11.15.4. Recent Developments
11.16. Exact Sciences Corporation
11.16.1. Company Overview
11.16.2. Financials
11.16.3. Products
11.16.4. Recent Developments
11.17. Biodesix (Integrated Diagnostics)
11.17.1. Company Overview
11.17.2. Financials
11.17.3. Products
11.17.4. Recent Developments
11.18. Freenome Holdings, Inc.
11.18.1. Company Overview
11.18.2. Financials
11.18.3. Products
11.18.4. Recent Developments
*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
- Market Snapshot
- Drivers : Impact Analysis
- Restraints : Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- List of Potential Buyers
- COVID-19 Impact Analysis by Production, Import, Export and Demand
- Pre V/S Post COVID-19
- Estimated Impact Of The Coronavirus (Covid-19) Epidemic
- COVID-19: Micro and Macro Factor Analysis
- Analysis by Product (USD MN)
- Instruments Market by Geography (USD MN)
- Kits and Consumables Market by Geography (USD MN)
- Services Market by Geography (USD MN)
- Analysis Market by Type (USD MN)
- Tissue Biopsies( Needle Biopsies, Fine Needle Aspiration (FNA), Core Needle Biopsy (CNB), Surgical Biopsies) Market by Geography (USD MN)
- Liquid Biopsies Market by Geography (USD MN)
- Others Market by Geography (USD MN)
- Analysis by Application (USD MN)
- Breast Cancer Market by Geography (USD MN)
- Colorectal Cancer Market by Geography (USD MN)
- Cervical Cancers Market by Geography (USD MN)
- Lung Cancers Market by Geography (USD MN)
- Prostate Cancers Market by Geography (USD MN)
- Skin Cancers Market by Geography (USD MN)
- Blood Cancers Market by Geography (USD MN)
- Kidney Cancers Market by Geography (USD MN)
- Liver Cancers Market by Geography (USD MN)
- Pancreatic Cancers Market by Geography (USD MN)
- Ovarian Cancers Market by Geography (USD MN)
- Global Cancer Biopsy Market by Geography (USD MN)
- North America Market Analysis (USD MN)
- United State Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate by Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisiton
LIST OF FIGURES
- Research Scope of Cancer Biopsy Report
- Market Research Process
- Market Research Methodology
- Global Cancer Biopsy Market Size, by Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis by Product
- Market Attractiveness Analysis by Type
- Market Attractiveness Analysis by Application
- Market Attractiveness Analysis by Region
- Value Chain Analysis
- Global Market Analysis by Product (USD MN)
- Instruments Market by Geography (USD MN)
- Kits and Consumables Market by Geography (USD MN)
- Services Market by Geography (USD MN)
- Global Market Analysis by Type (USD MN)
- Tissue Biopsies( Needle Biopsies, Fine Needle Aspiration (FNA), Core Needle Biopsy (CNB), Surgical Biopsies) Market by Geography (USD MN)
- Liquid Biopsies Market by Geography (USD MN)
- Others Market by Geography (USD MN)
- Global Market Analysis by Application (USD MN)
- Breast Cancer Market by Geography (USD MN)
- Colorectal Cancer Market by Geography (USD MN)
- Cervical Cancers Market by Geography (USD MN)
- Lung Cancers Market by Geography (USD MN)
- Prostate Cancers Market by Geography (USD MN)
- Skin Cancers Market by Geography (USD MN)
- Blood Cancers Market by Geography (USD MN)
- Kidney Cancers Market by Geography (USD MN)
- Liver Cancers Market by Geography (USD MN)
- Pancreatic Cancers Market by Geography (USD MN)
- Ovarian Cancers Market by Geography (USD MN)
- Global Market by Revenue
- North America Market by Revenue
- Europe Market by Revenue
- Asia Pacific Market by Revenue
- Latin America Market by Revenue
- Middle East & Africa Market by Revenue
- Recent Development in Industry
- Company Market Share Analysis
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
Related Categories
Medical Devices
Buy Chapters or Sections
Avail customized purchase options to meet your exact research needs:
- Buy sections of this report
- Buy country level reports
- Request for historical data
- Request discounts available for Start-Ups & Universities
Objectives of Study
- Define and measure the global market
- Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
- Analyze and identify major market trends along with the factors driving or inhibiting the market growth
- Study the company profiles of the major market players with their market share
- Analyze competitive developments